Julia Weisinger
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemia.
Journal: Blood
Published: August 19, 2025
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.
Journal: Blood
Published: August 19, 2025
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
Journal: The journal of pathology. Clinical research
Published: July 26, 2023
Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.
Journal: International journal of molecular sciences
Published: February 02, 2023
Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry.
Journal: Pathology oncology research : POR
Published: June 17, 2022
Screening and monitoring of the BTKC481S mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy.
Journal: British journal of haematology
Published: January 25, 2021
Management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia
Journal: Orvosi hetilap
Published: December 29, 2020
Retrospective analysis of chronic myeloid leukemia patients treated in the Department of Internal Medicine and Oncology, Semmelweis University, between 2003 and 2019
Journal: Orvosi hetilap
Published: November 25, 2020
Mild Clinical Course of COVID-19 Infection in Chronic Myeloid Leukemia (CML) Patients Receiving Tyrosine Kinase Inhibitors (TKIs) without Interruption.
Journal: Mediterranean journal of hematology and infectious diseases
Published: November 17, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026